Sciclone Pharmaceut (SCLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 86,228 | 96,831 | 86,988 | 87,470 | 85,803 |
| Marketable Securities | 75 | 75 | 75 | 75 | 75 |
| Receivables | 40,268 | 33,928 | 35,768 | 32,271 | 39,771 |
| Inventories | 10,703 | 14,197 | 16,264 | 14,049 | 15,238 |
| Income taxes - deferred | 326 | 7 | 5 | 107 | 6 |
| TOTAL | $140,197 | $146,700 | $141,344 | $136,461 | $143,417 |
| Non-Current Assets | |||||
| PPE Net | 1,848 | 1,577 | 1,187 | 1,026 | 843 |
| Intangibles | 34,521 | 34,886 | 34,521 | 34,435 | 35,357 |
| Other Non-Current Assets | 5,265 | 3,036 | 404 | 270 | 242 |
| TOTAL | $41,634 | $39,499 | $36,112 | $35,731 | $36,442 |
| Total Assets | $181,831 | $186,199 | $177,456 | $172,192 | $179,859 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 0 | 0 | 1,608 | 1,651 |
| Accounts payable and accrued liabilities | 5,311 | 6,364 | 6,567 | 3,276 | 7,716 |
| Accrued Expenses | 20,536 | 19,591 | 16,735 | 15,832 | 20,938 |
| TOTAL | $26,443 | $25,955 | $23,307 | $23,560 | $33,220 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 596 | 0 | 5 | 2,844 | 2,915 |
| Other Non-Current Liabilities | 114 | 55 | 41 | 76 | 44 |
| TOTAL | $114 | $55 | $41 | $177 | $44 |
| Total Liabilities | $26,557 | $26,010 | $23,348 | $23,737 | $33,264 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 50,056 | 50,774 | 51,080 | 51,494 | 51,958 |
| Common Shares | 50 | 51 | 51 | 52 | 52 |
| Retained earnings | -135,148 | -128,799 | -130,775 | -134,395 | -135,960 |
| Other shareholders' equity | 3,264 | 3,710 | 3,402 | 3,317 | 4,176 |
| TOTAL | $155,274 | $160,189 | $154,108 | $148,455 | $146,595 |
| Total Liabilities And Equity | $181,831 | $186,199 | $177,456 | $172,192 | $179,859 |